Open Access
Second-Line Systemic Therapy for Highly Aggressive Neuroendocrine Prostate Cancer
NAOHIRO FUJIMOTO, YUTO TSUBONUMA, YUJIRO NAGATA, AKINORI MINATO, IKKO TOMISAKI, KENICHI HARADA and HIROSHI MIYAMOTO
Anticancer Research September 2023, 43 (9) 3841-3847; DOI: https://doi.org/10.21873/anticanres.16571